Curanex Pharmaceuticals C... (CURX)
NASDAQ: CURX
· Real-Time Price · USD
1.31
-0.20 (-13.25%)
At close: Sep 18, 2025, 3:59 PM
1.24
-5.29%
After-hours: Sep 18, 2025, 07:59 PM EDT
Company Description
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases.
It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne.
The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023.
The company was founded in 1996 and is headquartered in Jericho, New York.
Curanex Pharmaceuticals Common Stock
| Country | United States |
| IPO Date | Aug 26, 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | n/a |
| CEO | Jun Liu |
Contact Details
Address: 2 Jericho Plaza Jericho, New York United States | |
| Website | https://www.curanexpharma.com |
Stock Details
| Ticker Symbol | CURX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0002025942 |
| CUSIP Number | n/a |
| ISIN Number | US23126K1060 |
| Employer ID | 83-0741390 |
| SIC Code | 2834 |
Key Executives
No executives data available.Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 12, 2025 | 8-K | Current Report |
| Sep 09, 2025 | 10-Q | Quarterly Report |
| Sep 02, 2025 | 3 | Filing |
| Sep 02, 2025 | 3 | Filing |
| Sep 02, 2025 | 3 | Filing |
| Sep 02, 2025 | 3 | Filing |
| Sep 02, 2025 | 3 | Filing |
| Sep 02, 2025 | 3 | Filing |
| Sep 02, 2025 | 3 | Filing |
| Sep 02, 2025 | 3 | Filing |